DOCSLIB.ORG

Medications and Foods Certain Drugs and Foods Do Not Mix Well with Ultraviolet Light

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medications and Foods Certain Drugs and Foods Do Not Mix Well with Ultraviolet Light Photosensitizing Medications and Foods Certain drugs and foods do not mix well with ultraviolet light. This brochure contains a PARTIAL list of substances which could sensitize your skin to ultraviolet light. ALWAYS REMEMBER TO TELL YOUR TANNING Astemizole Dacarbazine Gentamicin Methylene blue Profriptyline (Vivactil) (Dartal) Auranofin Danazol Glipizide Methylene orange Promazine Hydrochloride (Sparine) Thioridazine SALON OPERATOR IF YOU ARE TAKING ANY NEW Aureomycin Daratal Glyburide Methylene red Promethazine Thiosulfil-A MEDICATIONS, OR HAVE CHANGED MEDICATIONS. Azatadine Deconamine Glyceryl P- Aminobenzoate Methylene violet Promethazine Hydrochloride Thiothixene Azo Gantanol Demeclocycline (Declomycin, (sunscreen) Metolazone (Phenergan) Thorazine Azo Ganstisin Demethyl-chlortetracycline) Gold Salts (Compounds) Minizide Protriptyline Timolide Bactrim Demi-Regroton Gold Sodium Thiomalate Minocycline Psoralen (Ox-, Tri-, Meth-, Ultra-, etc.) Tolazamide Miscellaneous Classification of Photosensitizing Agents Barbiturates Despipramine (Norpramin, Griseofulvin (Fulvicin) Minocycline and Oil of: Bergamot, Pseudafed Tolazamide and Tolbutamide Bavachi (corylifolia) Pertofrane) Griseofulvin Ultramicrosize Lime, Cedar, Lavendar, Citron, Pyrathiazine Hydrochloride Tolbutamide Belladonna & Opium Dexchlorpheniramine Halogenated carbanilides and Sandalwood (Pyrrolazote) Tolbutamide (Orinase) Antihistimines Oral Contraceptives Rectal Suppositories Diabinese Halogenated phenols Minoxidol Pyrazinamide Toluene Anticonvulsants and Estrogen Bendroflumethiazide Dibenzopyran derivatives Halogenated salicylanilides Moduretic Pyridinc Toluidine blue Antifungals Major Tranquilizers Benzedryl Diclofenac Haloperidol Monochlorphenamide Quinethazone (Hydromox) Trandate HCT Antiinflammotory Drugs Oral Diabetes Medications Benzene Dicyanine-A Hematoporphyrin Monoglycerol paraaminobenzoate Quinidine Tranylcypromine Benzopyrine Diethylstilbestrol Hexachlorophene (rare) Muromonab- CD3 Quinidine Gluconate Tretinoin (Ibuprofen, Ketoprofen, that are Sulphur Based Benthiazide Diflunisal Hydrochlorothiazide (Esidri, Musk Ambrette Quinidine Sulfate Triaminic TR Naproxen, etc.) Diuretics (Fluid Pills) Betaxolol Digaloyl Trioleate (sunscreen) HydroDiuril) Nabilone Quinidine Polygalecturonate Triamterene Antiseptics Some Antimalarials-Fansidar Bithionol (Actamer, Lorothidol) Digitoxin Hydroflumethiazide Nadison Quinine Tribromosalicylanilide (TBS) Antibiotics (a Sulfa Drug) Blankophores (sulpha derivatives) Dilantin Hydrpres Nalidixic Acid (NegGram) Ramipril Trichlormethiazide (Metahydrin) Botulinum Toxin Type A Diltiazem Hydroxychloroquine Naphthalene Retin-A Tridione Anticholesterol Medications Chloroquine Bromchlorsalicylanilid Diphenhydramine Hydroxypropyl Cellulose Naproxen Rose bengal Triethylene Melamine (TEM) Antidepressants Some Deodorants, Perfumes, Bromodiphenhydramine Diphenylpraline Hyoscyamine Neuroleptics Rue Trifluoperazine Antipsychotic Medications Colognes, Cosmetics, Etc. Bulosemide (Jadit) Diupres Ibuprofen Neatral red Ru-Tuss II Trifluoperazine and Trifluopromazine Buspirone Diuretics Idoxuridine Nifedipine Salicylanilides Triflupromazine Hydrochloride Artificial Sweeteners Some Herbal Products- Butyl Chlorosalicylanilide Diuril Imapramine Norepinephrine Bitratrate Salicylates (Vesperin) Blood Pressure Medications St. John’s Wort Families Cadmium sulfide Diutensen-R Imapramine HCL (Trofranil) Norethynodrel and diethylstilbestrol Saluttensin/Salutensin-Demi Trilafon Coal Tar Products Some Sunscreens Calcifediol Doxazosin Indapamide Norfloxacin Selegiline Trimeprazine (“Tegrin”, “Denorex”, etc.) Tatoos Calcitriol Doxepin Inderide Normozide Ser-Ap-Es Trimeprazine Tartrate (Temaril) Calcium Cyclamate Doxycycline Indomethacin Nortriptyline (Aventryl) Serpasil-Esidrix Trimethadione (Tridione) Capozide Doxycycline Hyclate Interferon ALFA-2B Nortriptyline and Protriptyline Silver Salts Trimethoprim Captopril Dyazide Iohexol Ofloxacin Spansule Trimethylpsoralen Photosensitizing Foods Carbamazepine (Tegretol) Enalapril Isocarboxazid Olsalazine Sparine Tripyrathiazine Sulfamethoxazole Carbamazepine and Trimethadione Encainide Isothipencyl (Theruhistin) Orange Red Stibamidine Isethionate Trimipramine Carbinoxamine d-form (Twiston R-A) Enduronyl Isothipendly (Theruhistin) Oreticyl Sulfacetamide Trinalin Repetabs Carrots Grass (wheat, barley, etc.) Carbutamide (Nadisan) Eosin Isotretinoin Orinase (Orabetic) Sulfacytine Tripelennamine Celery Lady’s Thumb (tea) Chloraquine Erythrocine Ketoconazole Ornade Sulfadiazine Triprolidine Citrus Fruits Lime oil Chlordiazepoxide Erythrosin Ketoprofen Oxytetracycline (Terramycin) Sulfadimethoxine Triprolidine and Chlorpheniramine Chlorophyll Esimil Labetalol Pacatal Sulfaguanidine Tropicamide Clover Mustards Chlorothiazide (Diuril) Estazolam Lantinin Para-dimethylamino Azobenzene Sulfamerazine Trypaflavin Coumarin Onions Chlorpheniramine Estrogens Levamisole Paramethadione Sulfamethazine Trypan blue Dill Parsley Chlorpromazine Estrone Limbitrol Paraphenylenediamine Sulfamethoxazole Ultraoxpsoralen Eggs Parsnips (vegetables) Chlorpropamide (Diabinese) Ethambutol Lopressor HCT Pediazole Sulfanilamide Vaseretic Chlorprothixene Ethionamide Lovastatin Penicillin derivatives (Griseofulvin) Sulfapyridine Vesprin Figs Saint John’s Wort Chlortetracycline (Aureomycin) Ethosuximide Loxapine Pergolide Mesylate Sulfasalazine Water Ash Garlic Smartweed (tea) Chlorthalidone Etodolac Maprotiline Perloline Sulphathiazole Wood tars and Petroleum Ginko Biloba Vanilla Oils Ciprofloxacin Etrafon Maxzide Perphenazine Sulfinpyrazone products Clemastine Etretinate Meclothiazide (Enduron) Phenanthrene Phenazine dyes Sulfisomidine (Elkosin) Vidarabine Photosensitizing Agents Clofazime Fansidar Mepazine (Pacatal) Phenelzine Sulfisoxazole Vinblastine Clomiphene Fentichlor Mepergan Phenolic compounds Sulfonnamide(s) Xylene Acetazolamide Amiodarone Chlomipramine Flecainide Acetate Mephenytoin Phenothiazines (dyes) Sulfone Yarrow Acetophenazine Amitriptyline (Elavil, etc.) Coal Tars Floxuridine 9- Mercaptopurine Phenoxazines Sullfonylureas (antidiabetics) Zestoretic Acetohexamide (Dymelor) Amoxapine Coal Tar derivatives Flucytosine Mesoridazine Phenylbutazone (Butazolidin) Sulindac Zidovudine Acetohexamine Anesthetics (Procaine group) Cold Salts Fluorouracil Mestranol Phenylbutazone Temaril Acridine preparations (slight) Angelica Combipres 5- Fluorouracil (5-Fu) Methacycline Phenytoin (Dilantin) Tenoretic Actifed Anthracene Compazine Fluoxetine Methazolamide Piroxicam Terfenadine Agave Lechuguilla (amaryllis) Anthraquinone Contraceptives, oral Fluphenazine Methdilazine Pitch Terramycin Agrimony Antidepressants Corzide Flurbiprofen Methotrexate Polythiazide Tetrachlorasalicylanilide (TCSA) Aldactazide Antihistamines Chromolyn Flutamide Methoxsalen (Meloxine, Oxsoralen) Porphyrins Tetracyclines Aldoclor Antimalarials Cyclamates Fosinopril 5- Methoxypsoralen Prinzide Therahistin Aldoril Apresazide Cyclobenzaprine Furazolidone 8- Methoxypsoralen Procaine Thiazides (Diuril, Hydrodiuril, etc.) Aminoacridine Apresoline-Esidrix Cyclopentolate Furocoumarins Methsuximide Procarbazine Thiophene Aminobenzoic Acid Arsenicals Cyproheptadine Furosemide Methyclothiazide Prochloperazine Thiopropazate Dilhydrochloride.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0190743 A1 Bain Et Al
    US 2012O190743A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0190743 A1 Bain et al. (43) Pub. Date: Jul. 26, 2012 (54) COMPOUNDS FOR TREATING DISORDERS Publication Classification OR DISEASES ASSOCATED WITH (51) Int. Cl NEUROKININ 2 RECEPTORACTIVITY A6II 3L/23 (2006.01) (75) Inventors: Jerald Bain, Toronto (CA); Joel CD7C 69/30 (2006.01) Sadavoy, Toronto (CA); Hao Chen, 39t. ii; C Columbia, MD (US); Xiaoyu Shen, ( .01) Columbia, MD (US) A6IPI/00 (2006.01) s A6IP 29/00 (2006.01) (73) Assignee: UNITED PARAGON A6IP II/00 (2006.01) ASSOCIATES INC., Guelph, ON A6IPI3/10 (2006.01) (CA) A6IP 5/00 (2006.01) A6IP 25/00 (2006.01) (21) Appl. No.: 13/394,067 A6IP 25/30 (2006.01) A6IP5/00 (2006.01) (22) PCT Filed: Sep. 7, 2010 A6IP3/00 (2006.01) CI2N 5/071 (2010.01) (86). PCT No.: PCT/US 10/48OO6 CD7C 69/33 (2006.01) S371 (c)(1) (52) U.S. Cl. .......................... 514/552; 554/227; 435/375 (2), (4) Date: Apr. 12, 2012 (57) ABSTRACT Related U.S. Application Data Compounds, pharmaceutical compositions and methods of (60) Provisional application No. 61/240,014, filed on Sep. treating a disorder or disease associated with neurokinin 2 4, 2009. (NK) receptor activity. Patent Application Publication Jul. 26, 2012 Sheet 1 of 12 US 2012/O190743 A1 LU 1750 15OO 1250 OOO 750 500 250 O O 20 3O 40 min SampleName: EM2OO617 Patent Application Publication Jul. 26, 2012 Sheet 2 of 12 US 2012/O190743 A1 kixto CFUgan <tro CFUgan FIG.2 Patent Application Publication Jul.
    [Show full text]
  • FROM MELANCHOLIA to DEPRESSION a HISTORY of DIAGNOSIS and TREATMENT Thomas A
    1 FROM MELANCHOLIA TO DEPRESSION A HISTORY OF DIAGNOSIS AND TREATMENT Thomas A. Ban International Network for the History of Neuropsychopharmacology 2014 2 From Melancholia to Depression A History of Diagnosis and Treatment1 TABLE OF CONTENTS Introduction 2 Diagnosis and classifications of melancholia and depression 7 From Galen to Robert Burton 7 From Boissier de Sauvages to Karl Kahlbaum 8 From Emil Kraepelin to Karl Leonhard 12 From Adolf Meyer to the DSM-IV 17 Treatment of melancholia and depression 20 From opium to chlorpromazine 21 Monoamine Oxidase Inhibitors 22 Monoamine Re-uptake Inhibitors 24 Antidepressants in clinical use 26 Clinical psychopharmacology of antidepressants 30 Composite Diagnostic Evaluation of Depressive Disorders 32 The CODE System 32 CODE –DD 33 Genetics, neuropsychopharmacology and CODE-DD 36 Conclusions 37 References 37 INTRODUCTION Descriptions of what we now call melancholia or depression can be found in many ancient documents including The Old Testament, The Book of Job, and Homer's Iliad, but there is virtually 1 The text of this E-Book was prepared in 2002 for a presentation in Mexico City. The manuscript was not updated. 3 no reliable information on the frequency of “melancholia” until the mid-20th century (Kaplan and Saddock 1988). Between 1938 and 1955 several reports indicated that the prevalence of depression in the general population was below 1%. Comparing these figures, as shown in table 1, with figures in the 1960s and ‘70s reveals that even the lowest figures in the psychopharmacological era (from the 1960s) are 7 to 10 times greater than the highest figures before the introduction of antidepressant drugs (Silverman 1968).
    [Show full text]
  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
    US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG .
    [Show full text]
  • Lee County Environmental Health
    Lee County Environmental Health LICENSING OF TANNING FACILITIES CHAPTER 64E-17 The 1991 Florida Legislature passed a law which requires the licensing and monitoring of tanning facilities. The Florida Department of Health, through its County Health Departments, is responsible for licensing and monitoring these facilities for compliance with the law. Further information and downloads can be found at http://lee.floridahealth.gov/programs-and- services/environmental-health/tanning/index.html The following documents must be provided to the local Health Department prior to issuance of a tanning facility license. 1. Application for Tanning Facility License 2. Tanning Facility Equipment Information 3. Site-Plan (Review checklist attached; Site-Plan required with application). 4. Approved Tanning Certification (a list of approved training is provided and available on the DOH website) 5. Applicant Certification Form 6. Copy of Facility’s Operating and Safety Procedures 7. Certificate of insurance that provides liability insurance including limits of liability 8. Check in the amount due shown on the application or invoice should be made payable to: Florida Department of Health. Payment is due at time of application Please be reminded that the operation of your tanning facility without a current state license is a violation of Florida Administrative Code and that you are responsible for renewing your license annually as notified by this department. The deadline for license renewal is October 1st each year. If you have any questions regarding this matter, please do not hesitate to contact the Florida Department of Health in Lee County at 239-690-2100. 2295 Victoria Avenue, #206 Fort Myers, FL 33901 Phone: 239-690-2100 Fax: 239-690-2101 License Number HEALTH STATE OF FLORIDA DEPARTMENT OF HEALTH APPLICATION FOR TANNING FACILITY LICENSE AUTHORITY: SECTION 381 .89, Florida Statutes INSTRUCTIONS 1.
    [Show full text]
  • Using Medications, Cosmetics, Or Eating Certain Foods Can Increase Sensitivity to Ultraviolet Radiation
    USING MEDICATIONS, COSMETICS, OR EATING CERTAIN FOODS CAN INCREASE SENSITIVITY TO ULTRAVIOLET RADIATION. INDIVIDUALS SHOULD CONSULT A PHYSICIAN BEFORE USING A SUNLAMP, IF THEY ARE TAKING MEDICATIONS. THE ITEMS LISTED ARE POTENTIAL PHOTOSENSITIZING AGENTS THAT MAY INCREASE SENSITIVITY TO ULTRAVIOLET LIGHT THAT MAY RESULT IN A PHOTOTOXIC OR PHOTOALLERGIC RESPONSES. PHOTOSENSITIZING MEDICATIONS Acetazolamide Amiloride+Hydrochlorothizide Amiodarone Amitriptyline Amoxapine Astemizole Atenolol+Chlorthalidone Auranofin Azatadine (Optimine) Azatidine+Pseudoephedrine Bendroflumethiazide Benzthiazide Bromodiphenhydramine Bromopheniramine Captopril Captopril+Hydrochlorothiazide Carbaamazepine Chlordiazepoxide+Amitriptyline Chlorothiazide Chlorpheniramine Chlorpheniramin+DPseudoephedrine Chlorpromazine Chlorpheniramine+Phenylopropanolamine Chlorpropamide Chlorprothixene Chlorthalidone Chlorthalidone+Reserpine Ciprofloxacin Clemastine Clofazime ClonidineChlorthalisone+Coal Tar Coal Tar Contraceptive (oral) Cyclobenzaprine Cyproheptadine Dacarcazine Danazol Demeclocycline Desipramine Dexchlorpheniramine Diclofenac Diflunisal Ditiazem Diphenhydramine Diphenylpyraline Doxepin Doxycycline Doxycycline Hyclate Enalapril Enalapril+Hydrochlorothiazide Erythromycin Ethylsuccinate+Sulfisoxazole Estrogens Estrogens Ethionamide Etretinate Floxuridine Flucytosine Fluorouracil Fluphenazine Flubiprofen Flutamide Gentamicin Glipizide Glyburide Gold Salts (compounds) Gold Sodium Thiomalate Griseofulvin Griseofulvin Ultramicrosize Griseofulvin+Hydrochlorothiazide Haloperidol
    [Show full text]
  • Consultation Paper: International Harmonisation of Ingredient Names
    International Harmonisation of Ingredient Names (IHIN) Consultation paper Version 1.0, May 2013 Historical consultation document Therapeutic Goods Administration About the Therapeutic Goods Administration (TGA) · The Therapeutic Goods Administration (TGA) is part of the Australian Government Department of Health and Ageing, and is responsible for regulating medicines and medical devices. · The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. · The work of the TGA is based on applying scientific and clinical expertise to decision- making, to ensure that the benefits to consumers outweigh any risks associated with the use of medicines and medical devices. · The TGA relies on the public, healthcare professionals and industry to report problems with medicines or medical devices. TGA investigates reports received by it to determine any necessary regulatory action. · To report a problem with a medicine or medical device, please see the information on the TGA website <www.tga.gov.au>. Copyright © Commonwealth of Australia 2013 This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given specific written permission from the Commonwealth to do so.
    [Show full text]
  • Functionalisation of Graphene/Graphene Oxide and the Application of It and Its Derivatives in Nanomedicine
    KAUNAS UNIVERSITY OF TECHNOLOGY NORA ŠLEKIENĖ FUNCTIONALISATION OF GRAPHENE/GRAPHENE OXIDE AND THE APPLICATION OF IT AND ITS DERIVATIVES IN NANOMEDICINE Doctoral Dissertation Technological sciences, Chemical engineering (05T) 2016, KAUNAS UDK 546.26 + 615](043.3) The dissertation was prepared at the Kaunas University of Technology, the Research Centre for Microsystems and Nanotechnology of the Faculty of Mathematics and Natural Sciences during the period of 2012–2016. The studies were supported by the Research Council of Lithuania. Scientific Supervisor: Prof. Habil. Dr Valentinas SNITKA (Kaunas University of Technology, Technological sciences, Chemical engineering, 05T). This doctoral dissertation has been published in: http://ktu.edu English Language Editor: UAB “Synergium” © N. Šlekienė, 2016 ISBN 978-609-02-1284-4 KAUNO TECHNOLOGIJOS UNIVERSITETAS NORA ŠLEKIENĖ GRAFENO / GRAFENO OKSIDO FUNKCIONALIZAVIMAS IR JO BEI JO DARINIŲ TAIKYMAS NANOMEDICINOJE Daktaro disertacija Technologijos mokslai, chemijos inžinerija (05T) 2016, KAUNAS 3 UDK 546.26 + 615](043.3) Disertacija rengta 2012–2016 m. Kauno technologijos universitete, Matematikos ir gamtos mokslų fakultete, Mikrosistemų ir nanotechnologijų mokslo centre. Mokslinius tyrimus rėmė Lietuvos mokslo taryba. Mokslinis vadovas: Prof. habil. dr. Valentinas SNITKA (Kauno technologijos universitetas, technologijos mokslai, chemijos inžinerija, 05T). Interneto svetainės, kurioje skelbiama disertacija, adresas: http://ktu.edu Redagavo: UAB “Synergium” © N. Šlekienė, 2016 ISBN 978-609-02-1284-4
    [Show full text]
  • Medication List
    MEDICATION LIST Natural oils found in perfumes and colognes which contain furocoumarins, compounds from natural products such as plants and fruits, can sensitize the skin to sunlight. Food and fruit that contain photosensitizing agents: celery, carrots, lime, coriander, parsley, fennel, dill buttercup, mustard, and figs. Some known photosensitizing medications are listed below by name: Acetohexamide (Dymelor) Gold Salts Sandalwood oil (perfume) Acridine preparations (slight) Grass (meadow) Silver salts Agave Lechuguilla Griseofuivin (Fulvicin) Smartweed (tea) (amaryllis) Hematoporphyrin Sparine Agrimony Hexachlorophene (rare) Stilbamidine Isethionate 9-Aminoacrdine Hydrochlorothiazide Sulfacetamide Aminobenzoic Acid (Esidrix, HydroDiuril) Sulfadiazine Amitriptyline Imipramine HCL (Tofranil) Sulfadimethoxine (Elavil, etc) Isothipencyl (Theruhistin) Sulfaguanidine Anesthetics (Procaine group) Isothipendly (Theruhistin) Sulfanilamide Angelica L-Tryptophan Sulfamerazine Anthracene Lady=s Thumb (tea) Sulfamethazine Antimalarials Lantinin Sulfapyridine Arsenicals Lavender oil Sulfathiazole Barbiturates Lime oil Sulfonamides Bavachi (corylifolia) Meclothiazide (Enduron) Sulfisomidine (Elkosin) Benzene Mepazine (Pacatal) Sulfonylureas (antidiabetics) Benzopyrine 9-Mercaptopurine Temaril Bergamot (perfume) Methoxsalen (Meloxine, Oxsoralen) Terramycin Bithionol (Actamer, Lorothidol) 5-Methoxypsoralen Tetrachlorsalicylanilide (TCSA) Blankophores (sulfa derivatives) 8-Methoxypsoralen Tetracyclines Bulosemide (Jadit) Monoglycerol Thiazides (Diuril,
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,560,544 B2 Webber Et Al
    USOO756.0544B2 (12) United States Patent (10) Patent No.: US 7,560,544 B2 Webber et al. (45) Date of Patent: Jul. 14, 2009 (54) 3.5-DISUBSITITUTED AND 2003.01.00764 A1 5/2003 Bonket al. 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 2003,01628.06 A1 8, 2003 Dellaria et al. 3H-THIAZOLO4,5-DIPYRIMIDIN-2-ONE 2003/0176458 A1 9, 2003 Dellaria et al. COMPOUNDS AND PRODRUGS THEREOF 2003/0186949 A1 10, 2003 Dellaria et al. 2003. O195209 A1 10, 2003 Dellaria et al. (75) Inventors: Stephen E. Webber, San Diego, CA S-8. A. 1929 St.oberts etet al. al. (US); Gregory J. Haley, Del Mar, CA 2005, 0004144 A1 1/2005 Carson et al. (US); Joseph R. Lennox, San Diego, CA (US); Alan X. Xiang, San Diego, CA FOREIGN PATENT DOCUMENTS (US); Erik J. Rueden, Santee, CA (US) EP O 882 727 9, 1998 EP 1 035 123 9, 2000 (73) Assignee: Anadys Pharmaceuticals, Inc., San EP 1043 021 10, 2000 Diego, CA (US) EP 1386,923 A1 2, 2004 WO WO-89/05649 6, 1989 Notice: Subject to any disclaimer, the term of this WO WO-92, 16215 10, 1992 (*) WO WO-94,07904 4f1994 patent is extended or adjusted under 35 WO WO-94, 17043 8, 1994 U.S.C. 154(b) by 119 days. WO WO-94.17090 8, 1994 WO WO-98, 17279 4f1998 (21) Appl. No.: 11/304,691 WO WO-03/045968 6, 2003 (22) Filed: Dec. 16, 2005 OTHER PUBLICATIONS Vippagunta et al. Advanced Drug Delivery Reviews 48 (2001)3-26.* (65) Prior Publication Data Lugemwaetal.
    [Show full text]
  • (73) Assignee: Epicept Corporation, Englewood E. E. E. N. "...O's E Cliffs, NJ (US) 6,245,781 B1 6/2001 Upadhyay Et Al
    USOO6638981B2 (12) UnitedO States Patent (10) Patent No.: US 6,638,981 B2 Williams et al. (45) Date of Patent: Oct. 28, 2003 (54) TOPICAL COMPOSITIONS AND METHODS 6,191,131 B1 2/2001. He et al. .................... 514/246 FOR TREATING PAIN 6,191,165 B1 2/2001 Ognyanov et al. .......... 514/523 6,197.830 B1 3/2001 Frome ........................ 514/654 (75) Inventors: Robert O. Williams, Austin, TX (US); 3.24-Y-2 R : E.aS C al.al ...........- - - - - - sy: Feng Zhang, Austin, TX (US) 6,225,324 B1 5/2001 Poss et al. .................. 514/316 (73) Assignee: Epicept Corporation, Englewood E. E. E. N. "...O's E Cliffs, NJ (US) 6,245,781 B1 6/2001 Upadhyay et al. .......... 514/321 - 6,251,903 B1 6/2001 Cai et al. .................... 514/249 (*) Notice: Subject to any disclaimer, the term of this 6.251948 B1 6/2001 Weber et al. ............... 514/634 patent is extended or adjusted under 35 6.255,302 B1 7/2001 Kelly et al. ............ 514/217.05 U.S.C. 154(b) by 0 days. 6,387,957 B1 5/2002 Frome ........................ 514/647 6,461,600 B1 10/2002 Ford ....................... 424/78.02 (21) Appl. No.: 09/931,293 FOREIGN PATENT DOCUMENTS (22) Filed: Aug. 17, 2001 EP O 107 376 A1 5/1984 (65) Prior Publication Data EP O 577 394 A1 1/1994 WO WO 93/10163 5/1993 US 2003/0082214 A1 May 1, 2003 WO WO 94/13643 6/1994 (51) Int. Cl. .............................................. A61K31/135 W. WO 94/13644 6/1994 WO WO 94/13661 6/1994 (52) U.S.
    [Show full text]
  • PHOTOSENSITIZING LIST Certain Food/Drugs Do Not Mix with Ultraviolet Light
    PHOTOSENSITIZING LIST Certain food/drugs do not mix with ultraviolet light. Anyone taking any medication should consult with a Physican PRIOR to tanning. Antihistamines Amoxapine Coal Tar derivatives Fluorouracil Anticonvulsants Anesthetics (Procaine Cold Salts 5-Fluorouracil (5-Fu) Antifungals group) Combipres Fluoxetine Anti-inflammotory Angelica Compazine Fluphenazine drugs (Ibuprofen, Anthracene Contraceptives, oral Flurbiprofen Ketoprofen, Anthraquinone Corzide Flutamide Naproxen, etc.) Antidepressants Chromolyn Fosinopril Antiseptics Antihistamines Cyclamates Furazolidone Antibiotics Antimalarials Cyclobenzaprine Furocoumarins Anticholesterol Apresazide Cyclopentolate Furosemide medications Apresoline-Esidrix Cyproheptadine Gentamicin Antidepressants Arsenicals Dacarbazine Glipizide Antipsychotic Medications Astemizole Danazol Glyburide Artificial Sweeteners Auranofin Daratal Glyceryl P Aminobenzoate Blood Pressure Medications Aureomycin Deconamine (sunscreen) Coal Tar Productions Azatadine Demeclocycline Gold Salts (compounds) (Tegrin, Denorex) Azo Gantanol Declomycin Gold Sodium Thiomalate Oral Contaceptives & Azo Ganstisin Demethyl Griseoflulvin (Fulvicin) estrogen Bactrim chlortetracycline Griseofulvin Ultramicrosize Major Tranquilizers Barbiturates Demi-Regroton Halogenated Oral Diabetes meds Bavachi (corylifolia) Despipramine carbanilides Sulphur based meds Belladonna & Opium (Norpramin Halogenated phenols Diuretics (fluid Pills) Rectal suppositories pertofrane) Halogenated Some Antimalarials- Bendroflumethiazine Dexchlorpheniramine
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,288,372 B2 Hale Et Al
    US008288372B2 (12) United States Patent (10) Patent No.: US 8,288,372 B2 Hale et al. (45) Date of Patent: *Oct. 16, 2012 (54) METHOD FORTREATING HEADACHE 5,049,389 A 9, 1991 Radhakrishnan WITH LOXAPINE 5,060.671 A 10, 1991 Counts et al. 5,099,861 A 3, 1992 Clearman et al. 5,135,009 A 8, 1992 Muller et al. (75) Inventors: Ron L. Hale, Woodside, CA (US); 5,144.962 A 9, 1992 Counts et al. Patrik Munzar, Belmont, CA (US); 5,146,915 A 9/1992 Montgomery Joshua D. Rabinowitz, Mountain View, 5,224,498 A 7/1993 Deevi et al. 5,284,133 A * 2/1994 Burns et al. .............. 128.200.23 CA (US) 5,345,951 A 9, 1994 Serrano et al. 5,364,838 A 11/1994 RubSamen (73) Assignee: Alexza Pharmaceuticals, Inc., 5,366,770 A 1 1/1994 Wang Mountain View, CA (US) 5,388,574 A 2/1995 Ingebrethsen 5.431,167 A 7, 1995 Savord (*) Notice: Subject to any disclaimer, the term of this 5,456,247 A 10/1995 Shilling et al. patent is extended or adjusted under 35 5,511,726 A 4/1996 Greenspan et al. 5,522,385 A 6/1996 Lloyd et al. U.S.C. 154(b) by 1104 days. 5,564,442 A 10, 1996 MacDonald et al. This patent is Subject to a terminal dis 5,592,934 A 1/1997 Thwaites 5,605,146 A 2, 1997 Sarella claimer. 5,649,554 A 7/1997 Sprinkel et al. 5,666,977 A 9/1997 Higgins et al.
    [Show full text]